This inventor holds 1 USPTO granted patent. Top assignee: Lg Chem-Investment Ltd.. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: The Innovative Contributions of Sung Tak Oh
Introduction
Sung Tak Oh is a notable inventor based in Taegu, South Korea. He has made significant contributions to the field of chemistry, particularly in the development of novel processes for synthesizing important chemical compounds. His work is particularly relevant in the context of anti-cancer research.
Latest Patents
Sung Tak Oh holds a patent for a process titled "Process for preparing 4-substituted 1H-pyrrole-3-carboxylic acid ester." This invention relates to a novel method for preparing pyrrole ester compounds, which serve as key intermediates in the synthesis of farnesyl transferase inhibitors. These inhibitors are recognized for their potential as anti-cancer agents. The process utilizes the Horner-Emmons reaction of aldehyde compounds to produce the corresponding α,β-unsaturated esters. Notably, this method allows for the transformation into pyrrole esters in a one-pot fashion, eliminating the need for any separation or purification steps.
Career Highlights
Sung Tak Oh is associated with LG Chem Investment Ltd., a prominent company in the chemical industry. His work at LG Chem has allowed him to focus on innovative chemical processes that have significant implications for pharmaceutical development. With a total of 1 patent, his contributions are recognized within the scientific community.
Collaborations
Sung Tak Oh has collaborated with notable colleagues, including Hyun Ik Shin and Jay Hyok Chang. These collaborations have further enhanced the research and development efforts in their respective fields.
Conclusion
Sung Tak Oh's innovative work in the field of chemistry, particularly in the synthesis of pyrrole ester compounds, showcases his commitment to advancing anti-cancer research. His contributions are valuable to both the scientific community and the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile